Results 161 to 170 of about 24,176 (291)
Effects of SGLTi on Individual Clinical Endpoints and Quality‐of‐Life: outcome from randomized data. Abstract Aims Sodium–glucose co‐transporter inhibitors (SGLTis) have cardiovascular protective effects. We aimed to assess the effects of SGLTis on individual hard clinical endpoints and quality of life (QoL) in patients with cardiovascular risk factors.
Jia Liao+27 more
wiley +1 more source
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher+12 more
wiley +1 more source
Tricky acute mesenteric ischemia: what can we do? [PDF]
Cui X, Chen Y, Guan G, Luo F, Zhang Z.
europepmc +1 more source
Abstract Aims Targeting inflammasomes in heart failure (HF) might represent a novel therapeutic option. Nevertheless, previous studies focused only on myocardial inflammasome alterations, and data are scarce regarding their regulation and role in HF‐associated multiorgan dysfunction.
Dávid Nagy+12 more
wiley +1 more source
Acute arterial mesenteric ischaemia: comparison of partial and complete occlusion of the superior mesenteric artery. [PDF]
Dufay R+9 more
europepmc +1 more source
Infrainguinal arterial reconstructions in patients with aortoiliac occlusive disease: The influence of iliac stenting [PDF]
Carlos H. Timaran+3 more
openalex +1 more source
Abstract Aims This study evaluated the prognostic value of the relative apical sparing pattern (RASP) of longitudinal strain (LS) in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR) and investigated whether its combination with pre‐procedural biomarkers enhances risk stratification.
Dan Liu+8 more
wiley +1 more source
Cobalamin C deficiency: a rare but treatable genetic cause of pulmonary hypertension. [PDF]
Grynblat J, Coulet F, Montani D.
europepmc +1 more source